Article
Low risk of nevirapine resistance mutations in the prevention of mother-to-child transmission of HIV-1: Agence Nationale de Recherches sur le SIDA Ditrame Plus, Abidjan, Cote d'Ivoire.
The Journal of infectious diseases - 15 Feb 2006
Chaix Marie-Laure, Ekouevi Didier Koumavi, Rouet Francois, Tonwe-Gold Besigin, Viho Ida, Bequet Laurence, Peytavin Gilles, Toure Hassane, Menan Herve, Leroy Valeriane, Dabis Francois, Rouzioux Christine
Abstract excerpt
The frequency of resistance mutations was estimated in the cohort of Agence Nationale de Recherches sur le SIDA Ditrame Plus, a study that evaluated the combination of short-course zidovudine (ZDV) plus lamivudine (3TC) and single-dose nevirapine (SD-NVP) followed by 3 days of postpartum ZDV plus 3TC for the prevention of mother-to-child transmission of human immunodeficiency virus type 1 (HIV-1). The frequency...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.